Ulcerative Colitis Market Share, Size, Growth, Opportunity and Forecast Till 2023-2033

CALIFORNIA CITY, Calif. - Feb. 13, 2023 - PRLog -- The Vascular Screening Devices Market is expected to register a CAGR of 5.9% during the forecast period. The growing burden of vascular diseases and the rising geriatric population might be the key factors in the vascular screening devices market. Peripheral artery disease is a condition wherein the peripheral vessels are built up with fat and cholesterol deposits. According to the Current Atherosclerosis Reports, in 2018, peripheral artery disease affected almost 200 million people globally. Moreover, peripheral artery disease is more prevalent in the older population.

According to a similar source, the incidence of peripheral artery disease is observed to increase by approximately 20% in the population aged 70 and over. Moreover, rising awareness of non-invasive techniques for diagnostic purposes is expected to drive the market. Ankle, Branchial Index (ABI), toe-branchial index, and photoplethysmogram are some of the non-invasive techniques used for the diagnosis of vascular diseases. According to the study of 2018 published in Annals of Vascular Surgery, these tests were observed to be less painful for patients and consumed less time. Hence, such factors are expected to propel the vascular screening devices market growth.

Key Market Trends

Portable Segment is Expected to Hold a Major Market Share in the Vascular Screening Devices Market

Portable vascular screening test are hand-held devices which are in screening test. The rising burden of cardiovascular disease and other vascular conditions. According to the World Health Organization, in 2017, approximately 17.9 million people died due to cardiovascular diseases and it's the leading cause of death globally. For several of cardiovascular diseases, the vascular screening tests becomes very important for further analysis and treatment.

Furthermore, according to the assessment study of the International Journal of Cardiology, 2019, it was observed that the handheld device accurately measured the maximum plaque height and total plaque area in the carotid artery. Hence, early diagnosis and treatment are of utmost importance which is expected to impact positively on the vascular screening test market.

Competitive Landscape

In the current scenario, few of the companies that are dominating the Vascular Screening Devices Market are Fukuda, Unetixs Vascular Inc., Collaborative Care Diagnostics, LLC (Biomedix), CorVascular Diagnostics, LLC, Koven Technology, Inc., D.E. Hokanson, Inc., enverdis GmbH, OMRON HEALTHCARE Co., Ltd., Viasonix and Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

About US

SDKI Inc. (https://www.sdki.jp/)'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.